An Overview of Bernard–Soulier Syndrome – ICHCC
Iranian Comprehensive Hemophilia Care Center (ICHCC) shared a post on LinkedIn:
“Bernard–Soulier Syndrome (BSS)
When platelets are present, but don’t function properly!
Bernard–Soulier Syndrome (BSS) is a rare inherited platelet disorder caused by a defect in the GPIb-IX-V receptor complex on the platelet surface.
What is the role of this receptor?
The GPIb receptor binds to von Willebrand factor (vWF) and mediates the initial adhesion of platelets to injured blood vessels.
In BSS, this critical first step of primary hemostasis is impaired, resulting in a bleeding tendency.
Clinical Features:
- Easy bruising
- Recurrent epistaxis
- Gingival bleeding
- Menorrhagia in adolescent girls and women
- Prolonged bleeding after surgery or dental procedures
Typical Laboratory Findings:
- Mild to moderate thrombocytopenia
- Giant platelets on peripheral blood smear
- Prolonged bleeding time (or abnormal platelet function testing)
- Normal PT and aPTT
Key Examination Point:
On platelet aggregation studies: Reduced or absent response to ristocetin.
However: The abnormality is not corrected by adding normal plasma, helping differentiate BSS from von Willebrand disease.
Genetics: Most cases are inherited in an autosomal recessive pattern and are more common in populations with consanguineous marriages.
Management:
- Bleeding prevention and patient education
- Avoidance of aspirin and NSAIDs
- Tranexamic acid for mucosal bleeding
- Platelet transfusion for major bleeding episodes or surgical procedures
Clinical Pearl:
A patient with mucocutaneous bleeding, giant platelets, thrombocytopenia, and an abnormal ristocetin response should raise strong suspicion for Bernard–Soulier Syndrome.
Take-Home Message:
Bernard–Soulier Syndrome – Big Platelets plus Bleeding plus Defective Ristocetin Response.”

Other posts featuring ICHCC on Hemostasis Today.
-
Sep 21, 2026, 15:56Anita Zaidi: Why Only 2% of Health Research and Development Goes to Women’s Conditions
-
Sep 21, 2026, 15:49Omid Khalafi: Gating Strategy and How Do We Decide Which Cells to Analyze
-
Sep 21, 2026, 15:44Levacetylleucine: A New Therapeutic Approach to Ataxia Telangiectasia
-
Sep 21, 2026, 15:40Andreas Tridimas: The Diagnostic Traps of Lipaemic Blood – Why a Normal Amylase Can Mislead You
-
Sep 21, 2026, 15:33Arsene Mekinian: Exploring Cardiac Involvement in Behçet’s Disease
-
Sep 21, 2026, 15:23Anis Mahjoubi: MRI Findings of Krukenberg Tumors
-
Sep 21, 2026, 15:08Fikreab Tesfaye Tefera: 10 Practical Take-Home Points for Diagnosing Iron Deficiency Anemia
-
Sep 21, 2026, 14:10Aswin K Mohan: Lessons from TRANSCON 2026 – Building Resilient Blood Supply Systems Before Crisis Hits
-
Sep 21, 2026, 14:00Vincent Lu: Beyond PT and aPTT – How Hemostasis Evolves Across a Lifetime